Oral Mesalazine (5-ASA) Treatment May Protect Against Proximal Extension of Mucosal Inflammation in Ulcerative Proctitis-Reference-Cited by-同舟云学术

Oral Mesalazine (5-ASA) Treatment May Protect Against Proximal Extension of Mucosal Inflammation in Ulcerative Proctitis

Published:2004-11 Issue:6 Volume:10 Page:731-736
ISSN:1078-0998
Container-title:Inflammatory Bowel Diseases
language:en
Short-container-title:Inflammatory Bowel Diseases

Author:

Pica Roberta,Paoluzi Omero Alessandro,Iacopini Federico,Marcheggiano Adriana,Crispino Pietro,Rivera Margherita,Bella Antonino,Consolazio Adriana,Paoluzi Paolo

Publisher

Oxford University Press (OUP)

Subject

Gastroenterology,Immunology and Allergy

Reference31 articles.

1. Progression of ulcerative proctosigmoiditis

2. Change in The Extent of Colonoscopic and Histological Involvement in Ulcerative Colitis Over Time

3. Clinical Course during the 1st Year after Diagnosis in Ulcerative Colitis and Crohn's Disease: Results of a Large, Prospective Population-based Study in Southeastern Norway, 1990-93

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of proctitis in ulcerative colitis and the place of biological therapies;Expert Opinion on Biological Therapy;2024-06-02

2. Ulcerative colitis;The Lancet;2023-08

3. Niclosamide Enema for Active Distal Ulcerative Colitis: A Phase 1, Open-Label Study;Inflammatory Bowel Diseases;2023-07-21

4. Clinical Features and Natural History of Paediatric Patients with Ulcerative Proctitis: A Multicentre Study from the Paediatric IBD Porto Group of ESPGHAN;Journal of Crohn's and Colitis;2023-07-01

5. IOIBD Recommendations for Clinical Trials in Ulcerative Proctitis: The PROCTRIAL Consensus;Clinical Gastroenterology and Hepatology;2022-11